Safety and Efficacy of Tisagenlecleucel (CTL019) in B-Cell Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults: The French Experience
Marie-Emilie Dourthe, et al.
Report of experience treating children with ALL at two hospitals in France in both clinical trials and the commercial setting. Results confirmed the efficacy of CTL019 with high response rates and encouraging outcomes in a heavily pretreated patient population